Yes alot of the meds I take far my copd gives me bad bad heartburn my Dr gave me some meds to take care of it nothing was strong enough over the counter .copd also makes you have a lot of aches and pains .but anytime it really hurts bad please go to the Dr cause a lot of the pains you have will seem to be mimicking some thing else but always get it checked out that way you'll know if it's part of the copd are something else. I hope this help have a.breathe easy day

I have been on two different inhalers one gave me a terrible rash in the groin area like I have never had and the other gave me a bad dry cough. After I talked to my doctor took me off of the lst one and tried another after I went back and mentioned the dry cough she took me off of that one and now on ATROVENT and use it with a Otpi Chamber and this is working fine for me. Talk to your Doc and tell them you would like to try another brand and see what they say. Just want to say my rash is gone and so is my cough. So far have not noticed anything with my new medication. I am not saying you should do this but it might help to try another product and see what happens./

I have been on spriva for 10 year and the only time I get heartburn is when I eat just before bedtime. It may be Gerd and you should have it checked out ASAP

Ive just realised ive been on the same inhaler for nearly two weeks and my reflux has been really bad for the last few days its probably a side effect of the inhaler

@A MyCOPDTeam Member.......
...........................................................................................................................................................................
It does replace Spiriva.for those of us on it....If you still use the old combination then no problems at all...Never said Not to...The Combination Meds we are on especially Ultibro is NOT to be used in conjunction with Spiriva. It was released in most countries of the world in 2014, but the FDA is lagging behind and still waiting or has just approved it.......Here is some info......
..................................................................................................................................................................

Fixed long-acting combinations of both anticholinergic and beta-agonist bronchodilators, not previously available, have been developed. A new fixed combination of glycopyrronium and indacaterol has been extensively evaluated in clinical trials and appears to be nearing US Food and Drug Administration (FDA) approval in the United States. Five phase 3 studies compared the fixed combination of glycopyrronium and indacaterol (Ultibro® Breezhaler®) with each single component or with tiotropium (Spiriva® HandiHaler®).

The trials, which involved 4842 patients with moderate to severe COPD, were randomized, placebo-controlled, and double-blinded and lasted from 3 to 64 weeks. One was a cross-over study. A systematic review of all of these trials showed that lung function, the trough forced expiratory volume in 1 second (FEV1) at 24 hours after a single dose, was significantly improved.

A second benefit is that the combination of 2 bronchodilators not only provides more potent bronchodilation, it also avoids the use of a corticosteroid. Those patients who have needed two bronchodilators to control symptoms have until recently been prescribed a long-acting antimuscarinic antagonist (LAMA) and a long-acting beta-agonist (LABA)-corticosteroid combination (eg, Advair® or Symbicort®). Often these patients have no need of a corticosteroid inhalation, nor do they obtain any benefit. The availability of a fixed LAMA-LABA combination makes available a potent 24-hour bronchodilator combination that does not contain a corticosteroid.
................................................................................

Published on 08/01/15 at 01:05pm

Novartis has submitted two new lung treatments for FDA approval after ‘robust’ Phase III trial results.

If approved, QVA149 and NVA237, which are designed to improve breathing in chronic obstructive pulmonary disease (COPD) patients, would be available in the US for the first time after being available in Europe and other regions for several years.

We in Australia have now started using these Combination Inhalers since 2014...and so has the UK, Europe and many other Countries, yet the FDA are still waiting to approve it...

Mentioned Users

A MyCOPDT...